GLSI

Greenwich Lifesciences Inc (GLSI)

US
$ 14.394.2%

Price Chart

Key Statistics

Market Cap
$ 148.25M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
18.81K
52W High
$ 16.50
52W Low
$ 8.06
Dividend Yield
0.00%
Beta
3.15

Technicals

50-Day MA
10.0956
200-Day MA
11.5163
52 Week High
16.5
52 Week Low
8.06

About GLSI

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Employees
4
Headquarters
Stafford, TX
CEO
Mr. Snehal S. Patel

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96